Systematic review of protein biomarkers of invasive behavior in glioblastoma (Q38165795)

30 August 2017

title

Systematic review of protein biomarkers of invasive behavior in glioblastoma (English)

1 reference

30 August 2017

0 references

1 reference

Eli T Sayegh

1

1 reference

30 August 2017

Gurvinder Kaur

series ordinal

2

1 reference

30 August 2017

Orin Bloch

series ordinal

3

1 reference

30 August 2017

Andrew T Parsa

series ordinal

4

1 reference

30 August 2017

publication date

24 November 2013

1 reference

30 August 2017

published in

Molecular Neurobiology

1 reference

30 August 2017

volume

49

1 reference

30 August 2017

issue

3

1 reference

30 August 2017

page(s)

1212-1244

1 reference

Malignant gliomas in adults

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Novel glioblastoma markers with diagnostic and prognostic value identified through transcriptome analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Prognostic significance of c-Met expression in glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

YKL-40 and matrix metalloproteinase-9 as potential serum biomarkers for patients with high-grade gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Gene expression-based molecular diagnostic system for malignant gliomas is superior to histological diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Brain tumor invasion rate measured in vitro does not correlate with Ki-67 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

The cancer biomarker problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Calpain 2 is required for glioblastoma cell invasion: regulation of matrix metalloproteinase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Migrating glioma cells activate the PI3-K pathway and display decreased susceptibility to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

NHERF-1: modulator of glioblastoma cell migration and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Antiangiogenic therapy using bevacizumab in recurrent high-grade glioma: impact on local control and patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Endogenous tenascin-C enhances glioblastoma invasion with reactive change of surrounding brain tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

miR-124a is frequently down-regulated in glioblastoma and is involved in migration and invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Prognostic significance of intracranial dissemination of glioblastoma multiforme in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Serum YKL-40, a new prognostic biomarker in cancer patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Molecular pathology in adult gliomas: diagnostic, prognostic, and predictive markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

MGMT gene silencing and benefit from temozolomide in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Expression of matrix metalloproteinases and their inhibitors in human brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Adenovirus-mediated expression of antisense MMP-9 in glioma cells inhibits tumor growth and invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Downregulation of MMP-9 in ERK-mutated stable transfectants inhibits glioma invasion in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

High expression of cathepsin B and plasminogen activator inhibitor type-1 are strong predictors of survival in glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Identification of MMP-9 specific microRNA expression profile as potential targets of anti-invasion therapy in glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Matrix metalloproteinase-2 and -9 expression in astrocytic tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Retracted: MMP-2 siRNA Inhibits Radiation-Enhanced Invasiveness in Glioma Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Up-regulation of angiopoietin-2, matrix metalloprotease-2, membrane type 1 metalloprotease, and laminin 5 gamma 2 correlates with the invasiveness of human glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Gliomas induce and exploit microglial MT1-MMP expression for tumor expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Identification of potential serum biomarkers of glioblastoma: serum osteopontin levels correlate with poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

TIMP-4 and CD63: new prognostic biomarkers in human astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Serum angiogenic profile of patients with glioblastoma identifies distinct tumor subtypes and shows that TIMP-1 is a prognostic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Low expression of tissue inhibitor of metalloproteinases-1 (TIMP-1) in glioblastoma predicts longer patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Differential expression and localization of TIMP-1 and TIMP-4 in human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Exploring the distinctive biological characteristics of pilocytic and low-grade diffuse astrocytomas using microarray gene expression profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Downregulation of the RECK-tumor and metastasis suppressor gene in glioma invasiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Expression of antisense uPAR and antisense uPA from a bicistronic adenoviral construct inhibits glioma cell invasion, tumor growth, and angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

In vitro inhibition of human glioblastoma cell line invasiveness by antisense uPA receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Inhibition of in vivo tumorigenicity and invasiveness of a human glioblastoma cell line transfected with antisense uPAR vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Specific interference of urokinase-type plasminogen activator receptor and matrix metalloproteinase-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth, and angiogenesis in gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

PAI-1 and EGFR expression in adult glioma tumors: toward a molecular prognostic classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Downregulation of uPARAP mediates cytoskeletal rearrangements and decreases invasion and migration properties in glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Modulation of glioma cell invasion and motility by adenoviral gene transfer of PAI-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Knockdown of TFPI-2 promotes migration and invasion of glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Post-translational regulation of cathepsin B, but not of other cysteine cathepsins, contributes to increased glioblastoma cell invasiveness in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Adenovirus-mediated expression of antisense urokinase plasminogen activator receptor and antisense cathepsin B inhibits tumor growth, invasion, and angiogenesis in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

The clinical significance of cathepsin S expression in human astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Cathepsin S expression: An independent prognostic factor in glioblastoma tumours--A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Cathepsin D is a potential serum marker for poor prognosis in glioma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Glioblastoma invasion, cathepsin B, and the potential for both to be inhibited by auranofin, an old anti-rheumatoid arthritis drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Metalloproteinase disintegrins ADAM8 and ADAM19 are highly regulated in human primary brain tumors and their expression levels and activities are associated with invasiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Inhibition of ADAM17 reduces hypoxia-induced brain tumor cell invasiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

ADAM17 regulates self-renewal and differentiation of U87 glioblastoma stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Human glioblastomas overexpress ADAMTS-5 that degrades brevican

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

The emerging roles of human tissue kallikreins in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Astrocyte elevated gene-1 upregulates matrix metalloproteinase-9 and induces human glioma invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Astrocyte elevated gene-1: a novel target for human glioma therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Molecular basis of nuclear factor-kappaB activation by astrocyte elevated gene-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

HC gp-39 gene is upregulated in glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

CHI3L1 (YKL-40) is expressed in human gliomas and regulates the invasion, growth and survival of glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and beta-catenin-TCF/Lef signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Tenascin-C protein is induced by transforming growth factor-beta1 but does not correlate with time to tumor progression in high-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Expression of tenascin in human gliomas: its relation to histological malignancy, tumor dedifferentiation and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Tenascin-C stimulates glioma cell invasion through matrix metalloproteinase-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Tenascin-C suppresses Rho activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Role of galectin-1 in migration and invasion of human glioblastoma multiforme cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Galectin-1 is highly expressed in human gliomas with relevance for modulation of invasion of tumor astrocytes into the brain parenchyma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Galectin-1, a gene preferentially expressed at the tumor margin, promotes glioblastoma cell invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Galectin-1 modulates human glioblastoma cell migration into the brain through modifications to the actin cytoskeleton and levels of expression of small GTPases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Knocking down galectin 1 in human hs683 glioblastoma cells impairs both angiogenesis and endoplasmic reticulum stress responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Multifaceted role of galectin-3 on human glioblastoma cell motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Galectin-3 as an immunohistochemical tool to distinguish pilocytic astrocytomas from diffuse astrocytomas, and glioblastomas from anaplastic oligodendrogliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Galectin-3: cellular distribution and correlation with WHO-grade in human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Galectin-3 and galectin-3-binding site expression in human adult astrocytic tumours and related angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Identification of genes differentially expressed in glioblastoma versus pilocytic astrocytoma using Suppression Subtractive Hybridization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Osteopontin increases heme oxygenase-1 expression and subsequently induces cell migration and invasion in glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Osteopontin regulates human glioma cell invasiveness and tumor growth in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

SPARC modulates cell growth, attachment and migration of U87 glioma cells on brain extracellular matrix proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Downregulation of SPARC expression inhibits cell migration and invasion in malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

SPARC upregulates MT1-MMP expression, MMP-2 activation, and the secretion and cleavage of galectin-3 in U87MG glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Gene expression profiling and genetic markers in glioblastoma survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Integrin beta3 overexpression suppresses tumor growth in a human model of gliomagenesis: implications for the role of beta3 overexpression in glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

αvβ8 integrin interacts with RhoGDI1 to regulate Rac1 and Cdc42 activation and drive glioblastoma cell invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Glioblastoma angiogenesis and tumor cell invasiveness are differentially regulated by β8 integrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Fascin expression [corrected] in glial tumors and its prognostic significance in glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Expression of fascin, an actin-bundling protein, in astrocytomas of varying grades.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Fascin expression in 90 patients with glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

The role of fascin in the migration and invasiveness of malignant glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumors but is absent in oligodendrogliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Semaphorin 5A and plexin-B3 inhibit human glioma cell motility through RhoGDIalpha-mediated inactivation of Rac1 GTPase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Increased invasive capacity of connexin43-overexpressing malignant glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Down-regulation of Connexin43 expression reveals the involvement of caveolin-1 containing lipid rafts in human U251 glioblastoma cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

The role of drebrin in glioma migration and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Fibulin-3 is uniquely upregulated in malignant gliomas and promotes tumor cell motility and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Silencing of Eps8 blocks migration and invasion in human glioblastoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Silencing of insulin-like growth factor-binding protein-2 in human glioblastoma cells reduces both invasiveness and expression of progression-associated gene CD24.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

An interaction between insulin-like growth factor-binding protein 2 (IGFBP2) and integrin alpha5 is essential for IGFBP2-induced cell mobility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Plasma IGFBP-2 levels predict clinical outcomes of patients with high-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Gene expression profiling of gliomas strongly predicts survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

IQGAP1 and IGFBP2: valuable biomarkers for determining prognosis in glioma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

IIp45, an insulin-like growth factor binding protein 2 (IGFBP-2) binding protein, antagonizes IGFBP-2 stimulation of glioma cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Inactivation of the invasion inhibitory gene IIp45 by alternative splicing in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

ADP-ribosylation factor 6 regulates glioma cell invasion through the IQ-domain GTPase-activating protein 1-Rac1-mediated pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Insulin growth factor-2 binding protein 3 (IGF2BP3) is a glioblastoma-specific marker that activates phosphatidylinositol 3-kinase/mitogen-activated protein kinase (PI3K/MAPK) pathways by modulating IGF-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

A novel extracellular Hsp90 mediated co-receptor function for LRP1 regulates EphA2 dependent glioblastoma cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

A novel splice variant of GLI1 that promotes glioblastoma cell migration and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Sp1 is upregulated in human glioma, promotes MMP-2-mediated cell invasion and predicts poor clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

STAT5 regulates glioma cell invasion by pathways dependent and independent of STAT5 DNA binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

STAT6 expression in glioblastoma promotes invasive growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

ZFP36 expression impairs glioblastoma cell lines viability and invasiveness by targeting multiple signal transduction pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

TWIST1 promotes invasion through mesenchymal change in human glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

TWIST is expressed in human gliomas and promotes invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Frizzled 4 regulates stemness and invasiveness of migrating glioma cells established by serial intracranial transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

The tyrosine kinase pyk2 promotes migration and invasion of glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Expression of tyrosine kinases FAK and Pyk2 in 331 human astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Extended survival of Pyk2 or FAK deficient orthotopic glioma xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Knockdown of cyclin D1 inhibits proliferation, induces apoptosis, and attenuates the invasive capacity of human glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Overexpression of SASH1 related to the decreased invasion ability of human glioma U251 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

RNAi-mediated inhibition of presenilin 2 inhibits glioma cell growth and invasion and is involved in the regulation of Nrg1/ErbB signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

ZEB2 mediates multiple pathways regulating cell proliferation, migration, invasion, and apoptosis in glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Genetic and epigenetic modifications of Sox2 contribute to the invasive phenotype of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Notch1 activation promotes renal cell carcinoma growth via PI3K/Akt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Specific knockdown of uPA/uPAR attenuates invasion in glioblastoma cells and xenografts by inhibition of cleavage and trafficking of Notch -1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Numbl inhibits glioma cell migration and invasion by suppressing TRAF5-mediated NF-κB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

BRG1 expression is increased in human glioma and controls glioma cell proliferation, migration and invasion in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Mer receptor tyrosine kinase promotes invasion and survival in glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

The catalytic phosphoinositol 3-kinase isoform p110δ is required for glioma cell migration and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Dynamin 2 mediates PDGFRα-SHP-2-promoted glioblastoma growth and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

The small GTPase RhoG mediates glioblastoma cell invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

HMGA1 expression in human gliomas and its correlation with tumor proliferation, invasion and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Oct-3/4 promotes migration and invasion of glioblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Proteolytic cleavage of protein tyrosine phosphatase mu regulates glioblastoma cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

PTPmu suppresses glioma cell migration and dispersal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

miR-221/222 overexpession in human glioblastoma increases invasiveness by targeting the protein phosphate PTPμ

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

MGMT modulates glioblastoma angiogenesis and response to the tyrosine kinase inhibitor sunitinib.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Protein kinase D2 is a novel regulator of glioblastoma growth and tumor formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Protein kinase D2 regulates migration and invasion of U87MG glioblastoma cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

GOLPH3 regulates the migration and invasion of glioma cells though RhoA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Expression of the Golgi phosphoprotein-3 gene in human gliomas: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Overexpression of Golgi phosphoprotein-3 (GOLPH3) in glioblastoma multiforme is associated with worse prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Deltex-1 activates mitotic signaling and proliferation and increases the clonogenic and invasive potential of U373 and LN18 glioblastoma cells and correlates with patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Cacospongionolide and scalaradial, two marine sesterterpenoids as potent apoptosis-inducing factors in human carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

FABP7 expression in glioblastomas: relation to prognosis, invasion and EGFR status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Ephrin-B3 ligand promotes glioma invasion through activation of Rac1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

The phosphorylation of EphB2 receptor regulates migration and invasion of human glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

EphA2 as a novel molecular marker and target in glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

EphB2/R-Ras signaling regulates glioma cell adhesion, growth, and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Netrin-1 promotes glioblastoma cell invasiveness and angiogenesis by multiple pathways including activation of RhoA, cathepsin B, and cAMP-response element-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Bex2 is critical for migration and invasion in malignant glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

AMOG/beta2 and glioma invasion: does loss of AMOG make tumour cells run amok?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Microarray analysis of gliomas reveals chromosomal position-associated gene expression patterns and identifies potential immunotherapy targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Overexpression of CD99 Increases the Migration and Invasiveness of Human Malignant Glioma Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Expression of emmprin (CD147), a cell surface inducer of matrix metalloproteinases, in normal human brain and gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Inhibition of basigin expression in glioblastoma cell line via antisense RNA reduces tumor cell invasion and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Clinical implications and prognostic value of EMMPRIN/CD147 and MMP2 expression in pediatric gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-interacting genes in human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

CD151 enhances cell motility and metastasis of cancer cells in the presence of focal adhesion kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Inhibition of Necl-5 (CD155/PVR) reduces glioblastoma dispersal and decreases MMP-2 expression and activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

CD155/PVR enhances glioma cell dispersal by regulating adhesion signaling and focal adhesion dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Receptors for hyaluronic acid and poliovirus: a combinatorial role in glioma invasion?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

CD166/activated leukocyte cell adhesion molecule is expressed on glioblastoma progenitor cells and involved in the regulation of tumor cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Expression of adhesion factors and degrading proteins in primary and secondary glioblastomas and their precursor tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Expression of the neural cell adhesion molecule in astrocytic tumors: an inverse correlation with malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Neural cell adhesion molecule isoform 140 declines with rise of WHO grade in human gliomas and serves as indicator for the invasion zone of multiform glioblastomas and brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Alteration of serum and tumoral neural cell adhesion molecule (NCAM) isoforms in patients with brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Transfection of glioma cells with the neural-cell adhesion molecule NCAM: effect on glioma-cell invasion and growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Migratory, invasive and metastatic capacity of NCAM transfected rat glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Polysialic acid facilitates tumor invasion by glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Polysialic acid neural cell adhesion molecule (PSA-NCAM) is an adverse prognosis factor in glioblastoma, and regulates olig2 expression in glioma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Expression of podoplanin in human astrocytic brain tumors is controlled by the PI3K-AKT-AP-1 signaling pathway and promoter methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

miR-29b and miR-125a regulate podoplanin and suppress invasion in glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Identification of novel genes associated with astrocytoma progression using suppression subtractive hybridization and real-time reverse transcription-polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

α-Catenin inhibits glioma cell migration, invasion, and proliferation by suppression of β-catenin transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Peroxisome proliferator-activated receptor γ agonist pioglitazone inhibits β-catenin-mediated glioma cell growth and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Knockdown of FRAT1 expression by RNA interference inhibits human glioblastoma cell growth, migration and invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Hypoxia can induce c-Met expression in glioma cells and enhance SF/HGF-induced cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

A novel one-armed anti-c-Met antibody inhibits glioblastoma growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Expression of the receptor tyrosine kinase Tie2 in neoplastic glial cells is associated with integrin beta1-dependent adhesion to the extracellular matrix.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Angiopoietin-2 induces human glioma invasion through the activation of matrix metalloprotease-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Inositol-requiring enzyme 1alpha is a key regulator of angiogenesis and invasion in malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Expression of hypoxia-inducible factor 1? in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Knock down of HIF-1alpha in glioma cells reduces migration in vitro and invasion in vivo and impairs their ability to form tumor spheres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Meta-analysis of glioblastoma multiforme versus anaplastic astrocytoma identifies robust gene markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Intracavitary VEGF, bFGF, IL-8, IL-12 levels in primary and recurrent malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Geranylgeranyltransferase I regulates HIF-1α promoting glioblastoma cell migration and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Glioblastoma inhibition by cell surface immunoglobulin protein EWI-2, in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Increased fibroblast growth factor-inducible 14 expression levels promote glioma cell invasion via Rac1 and nuclear factor-kappaB and correlate with poor patient outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

The human Fn14 receptor gene is up-regulated in migrating glioma cells in vitro and overexpressed in advanced glial tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

TROY (TNFRSF19) is overexpressed in advanced glial tumors and promotes glioblastoma cell invasion via Pyk2-Rac1 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Cdc42 and the guanine nucleotide exchange factors Ect2 and trio mediate Fn14-induced migration and invasion of glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

TNF receptor-associated factor 6 regulates proliferation, apoptosis, and invasion of glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Protein disulfide isomerase expression is related to the invasive properties of malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

EMR-3: a potential mediator of invasive phenotypic variation in glioblastoma and novel therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Novel report of expression and function of CD97 in malignant gliomas: correlation with Wilms tumor 1 expression and glioma cell invasiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Overexpression of CD97 confers an invasive phenotype in glioblastoma cells and is associated with decreased survival of glioblastoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Receptor "hijacking" by malignant glioma cells: a tactic for tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Formylpeptide receptor FPR and the rapid growth of malignant human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Production of angiogenic factors by human glioblastoma cells following activation of the G-protein coupled formylpeptide receptor FPR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

The G-protein-coupled formylpeptide receptor FPR confers a more invasive phenotype on human glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Autotaxin is overexpressed in glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Autotaxin: a secreted autocrine/paracrine factor that promotes glioma invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Knockdown of interferon-induced transmembrane protein 1 (IFITM1) inhibits proliferation, migration, and invasion of glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Intersectin1-s is involved in migration and invasion of human glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Human cytomegalovirus US28 found in glioblastoma promotes an invasive and angiogenic phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Costimulatory protein 4IgB7H3 drives the malignant phenotype of glioblastoma by mediating immune escape and invasiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

A dialog between glioma and microglia that promotes tumor invasiveness through the CCL2/CCR2/interleukin-6 axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

The autophagy-associated factors DRAM1 and p62 regulate cell migration and invasion in glioblastoma stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

ARK5 promotes glioma cell invasion, and its elevated expression is correlated with poor clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Aquaporin-4 in glioma invasion and an analysis of molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Regulation of brain tumor dispersal by NKCC1 through a novel role in focal adhesion regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

With-No-Lysine Kinase 3 (WNK3) stimulates glioma invasion by regulating cell volume

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Knockdown of RLIP76 expression by RNA interference inhibits invasion, induces cell cycle arrest, and increases chemosensitivity to the anticancer drug temozolomide in glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Circulating markers of angiogenesis, inflammation, and coagulation in patients with glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Knockdown of CypA inhibits interleukin-8 (IL-8) and IL-8-mediated proliferation and tumor growth of glioblastoma cells through down-regulated NF-κB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Interleukin-6 overexpression as a marker of malignancy in human gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

IL-6 promotion of glioblastoma cell invasion and angiogenesis in U251 and T98G cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Interleukin-6 gene amplification and shortened survival in glioblastoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

CXCL12-induced glioblastoma cell migration requires intermediate conductance Ca2+-activated K+ channel activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

CXCR4 expression mediates glioma cell invasiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Hypoxia- and vascular endothelial growth factor-induced stromal cell-derived factor-1alpha/CXCR4 expression in glioblastomas: one plausible explanation of Scherer's structures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

CXCR4 mediates the proliferation of glioblastoma progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Nestin, PDGFRbeta, CXCL12 and VEGF in glioma patients: different profiles of (pro-angiogenic) molecule expression are related with tumor grade and may provide prognostic information.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Cost of Migration: Invasion of Malignant Gliomas and Implications for Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Glioma invasion in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Glioblastoma multiforme: the terminator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Chemokines and glioma: invasion and more

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Sensing invasion: cell surface receptors driving spreading of glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Molecular targets of glioma invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

The in vitro motility of human gliomas increases with increasing grade of malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Tracking the invasiveness of human astrocytoma cells by using green fluorescent protein in an organotypical brain slice model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Biology of angiogenesis and invasion in glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Mediators of glioblastoma resistance and invasion during antivascular endothelial growth factor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Insulin growth factor-binding protein 2 is a candidate biomarker for PTEN status and PI3K/Akt pathway activation in glioblastoma and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

The different HMGA1 expression of total population of glioblastoma cell line U251 and glioma stem cells isolated from U251.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Guanylate binding protein 1 is a novel effector of EGFR-driven invasion in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Molecular mechanisms of glioma cell migration and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8593-5

Neuroepithelial stem cell marker nestin regulates the migration, invasion and growth of human gliomas

21 January 2018

1 reference

12 December 2020

A public database for gene expression in human cancers

1 reference

12 December 2020

Understanding glioma invasion: a necessity for effective therapy.

1 reference

12 December 2020

Differential effects of low- and high-dose GW2974, a dual epidermal growth factor receptor and HER2 kinase inhibitor, on glioblastoma multiforme invasion

1 reference

12 December 2020

Effect of silencing HIF-1α on proliferation, invasion and migration of glioblastoma U87 cells

1 reference

12 December 2020

Prognostic significance of co-overexpression of the EGFR/IGFBP-2/HIF-2A genes in astrocytomas

1 reference

12 December 2020

Tie2/TEK modulates the interaction of glioma and brain tumor stem cells with endothelial cells and promotes an invasive phenotype

1 reference

12 December 2020

In vivo expression of insulin-like growth factor-binding protein-2 in human gliomas increases with the tumor grade

1 reference

12 December 2020

Integrin α3 is overexpressed in glioma stem-like cells and promotes invasion

1 reference

12 December 2020

Intracellular NAD(H) levels control motility and invasion of glioma cells.

1 reference

12 December 2020

Use of the Matrigel-based assay to measure the invasiveness of leukemic cells

1 reference

12 December 2020

Synergistic down-regulation of urokinase plasminogen activator receptor and matrix metalloproteinase-9 in SNB19 glioblastoma cells efficiently inhibits glioma cell invasion, angiogenesis, and tumor growth

1 reference

12 December 2020

Expression of extracellular matrix components in a highly infiltrative in vivo glioma model

1 reference

12 December 2020

Netrin-1-induced activation of Notch signaling mediates glioblastoma cell invasion

1 reference

12 December 2020

Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype.

1 reference

12 December 2020

Expression and cellular localization of messenger RNA for plasminogen activator inhibitor type 1 in human astrocytomas in vivo

1 reference

12 December 2020

Expression of tissue factor pathway inhibitor 2 inversely correlates during the progression of human gliomas

1 reference

12 December 2020

Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival

1 reference

12 December 2020

Migfilin protein promotes migration and invasion in human glioma through epidermal growth factor receptor-mediated phospholipase C-γ and STAT3 protein signaling pathways

1 reference

12 December 2020

Semaphorin 5A and plexin-B3 regulate human glioma cell motility and morphology through Rac1 and the actin cytoskeleton

1 reference

12 December 2020

Prognostic and clinical implication of IL-6 expression in glioblastoma multiforme

1 reference

12 December 2020

Overexpression of a transmembrane isoform of neural cell adhesion molecule alters the invasiveness of rat CNS-1 glioma

1 reference

12 December 2020

TGF-β1 promotes motility and invasiveness of glioma cells through activation of ADAM17.

1 reference

12 December 2020

SPARC-induced migration of glioblastoma cell lines via uPA-uPAR signaling and activation of small GTPase RhoA.

1 reference

12 December 2020

Selective suppression of matrix metalloproteinase-9 in human glioblastoma cells by antisense gene transfer impairs glioblastoma cell invasion

1 reference

12 December 2020

RECK-mediated inhibition of glioma migration and invasion.

1 reference

12 December 2020

Silencing of IKKε using siRNA inhibits proliferation and invasion of glioma cells in vitro and in vivo

1 reference

12 December 2020

Epidermal growth factor module-containing mucin-like receptor 2 is a newly identified adhesion G protein-coupled receptor associated with poor overall survival and an invasive phenotype in glioblastoma.

1 reference

12 December 2020

STIM1 and Orai1 mediate CRAC channel activity and are essential for human glioblastoma invasion

1 reference

12 December 2020

Differential gene expression profiling in human brain tumors

1 reference

12 December 2020

Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques.

1 reference

12 December 2020

Alpha(v)beta3 and alpha(v)beta5 integrin expression in glioma periphery.

1 reference

12 December 2020

IL-6 augments the invasiveness of U87MG human glioblastoma multiforme cells via up-regulation of MMP-2 and fascin-1.

1 reference

12 December 2020

High serum level of plasminogen activator inhibitor-1 predicts histological grade of intracerebral gliomas

1 reference

12 December 2020

Expression of osteopontin in human glioma. Its correlation with the malignancy

1 reference

12 December 2020

The role of human tissue kallikreins 7 and 8 in intracranial malignancies

1 reference

12 December 2020

Secreted protein acidic and rich in cysteine promotes glioma invasion and delays tumor growth in vivo.

1 reference

12 December 2020

Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma

1 reference

12 December 2020

Tenascin mediates human glioma cell migration and modulates cell migration on fibronectin

1 reference

12 December 2020

Localization of gelatinase-A and gelatinase-B mRNA and protein in human gliomas

1 reference

12 December 2020

Ezrin expression in tissue microarray of primary and recurrent gliomas

1 reference

12 December 2020

Effects of SEMA3G on migration and invasion of glioma cells

1 reference

12 December 2020

Ezrin-dependent promotion of glioma cell clonogenicity, motility, and invasion mediated by BCL-2 and transforming growth factor-beta2.

1 reference

12 December 2020

Tenascin-C expression by angiogenic vessels in human astrocytomas and by human brain endothelial cells in vitro

1 reference

12 December 2020

Interferon regulatory factor 3 alters glioma inflammatory and invasive properties

1 reference

12 December 2020

Silencing hypoxia-inducible factor-1alpha inhibits cell migration and invasion under hypoxic environment in malignant gliomas.

1 reference

12 December 2020

Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma

1 reference

12 December 2020

17AEP-GA, an HSP90 antagonist, is a potent inhibitor of glioblastoma cell proliferation, survival, migration and invasion

1 reference

12 December 2020

ADAM17 promotes U87 glioblastoma stem cell migration and invasion

1 reference

12 December 2020

Invasion of human glioma cells is regulated by multiple chloride channels including ClC-3.

1 reference

12 December 2020

Galectins are differentially expressed in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas, and significantly modulate tumor astrocyte migration.

1 reference

12 December 2020

The role of Nrf2 in migration and invasion of human glioma cell U251.

1 reference

12 December 2020

Cancer stem-like cells of glioblastoma characteristically express MMP-13 and display highly invasive activity

1 reference

12 December 2020

Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression

1 reference

12 December 2020

Expression of the endogenous galactose-binding protein galectin-3 correlates with the malignant potential of tumors in the central nervous system

1 reference

12 December 2020

Stromal protein periostin identified as a progression associated and prognostic biomarker in glioma via inducing an invasive and proliferative phenotype

1 reference

12 December 2020

Gab2 expression in glioma and its implications for tumor invasion

1 reference

12 December 2020

Insulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion-enhancing genes.

1 reference

12 December 2020

Tenascin expression in astrocytomas correlates with angiogenesis

1 reference

12 December 2020

Immunohistochemical localization of plasminogen activator inhibitor type 1 in human brain tumors.

1 reference

12 December 2020

Expression of angiopoietin-2 in human glioma cells and its role for angiogenesis.

1 reference

12 December 2020

Elevated membrane-type matrix metalloproteinases in gliomas revealed by profiling proteases and inhibitors in human cancer cells.

1 reference

12 December 2020

10.1007/S12035-013-8593-5

Identifiers

DOI

1 reference

Dimensions Publication ID

30 August 2017

1037720765

0 references

1 reference